Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest

Journal of Thoracic and Cardiovascular Surgery

Volumn 128, Issue 4, 2004, Pages 602-608

  Khan, Tanveer A ^a   Bianchi, Cesario ^a   Voisine, Pierre ^a   Feng, Jun ^a   Baker, Jeralyn ^a   Hart, Melanie ^b   Takahashi, Minoru ^b   Stahl, Greg ^b   Sellke, Frank W ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

17; 25; 31

Indexed keywords

3 NITROTYROSINE; ADENOSINE DIPHOSPHATE; APROTININ; KALLIKREIN; MYELOPEROXIDASE; TETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; BLOOD VESSEL FUNCTION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CRYSTALLOID; DRUG RESPONSE; ENDOTHELIUM; ENZYME ACTIVITY; HEART ARREST; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MICROSCOPY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE; TISSUE SECTION; VASODILATATION;

ANIMALS; APROTININ; CORONARY CIRCULATION; HEART ARREST, INDUCED; MICROCIRCULATION; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; SERINE PROTEINASE INHIBITORS; SWINE; TIME FACTORS;

EID: 4644360059     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2004.02.037     Document Type: Article

References (30)

1. Kloner R.A., Jennings R.B. Consequences of brief ischemia stunning, preconditioning, and their clinical implications - part 1. Circulation. 104:2001;2981-2989
2. Kloner R.A., Jennings R.B. Consequences of brief ischemia stunning, preconditioning, and their clinical implications - part 2. Circulation. 104:2001;3158-3167
3. Sellke F.W., Boyle E.M. Jr, Verrier E.D. Endothelial cell injury in cardiovascular surgery the pathophysiology of vasomotor dysfunction. Ann Thorac Surg. 62:1996;1222-1228
4. Park J.L., Lucchesi B.R. Mechanisms of myocardial reperfusion injury. Ann Thorac Surg. 68:1999;1905-1912
5. Ambrosio G., Tritto I. Reperfusion injury experimental evidence and clinical implications. Am Heart J. 138:1999;S69-75
6. Mojcik C.F., Levy J.H. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg. 71:2001;745-754
7. Bull D.A., Maurer J. Aprotinin and preservation of myocardial function after ischemia-reperfusion injury. Ann Thorac Surg. 75:2003;S735-739
8. McCarthy R.J., Tuman K.J., O'Connor C., Ivankovich A.D. Aprotinin pretreatment diminishes postischemic myocardial contractile dysfunction in dogs. Anesth Analg. 89:1999;1096-1100
9. Hendrikx M., Rega F., Jamaer L., Valkenborgh T., Gutermann H., Mees U. Na(+)/H(+)-exchange inhibition and aprotinin administration promising tools for myocardial protection during minimally invasive CABG. Eur J Cardiothorac Surg. 19:2001;633-639
10. Pruefer D., Buerke U., Khalil M., Dahm M., Darius H., Oelert H., et al. Cardioprotective effects of the serine protease inhibitor aprotinin after regional ischemia and reperfusion on the beating heart. J Thorac Cardiovasc Surg. 124:2002;942-949
11. Sunamori M., Sultan I., Suzuki A. Effect of aprotinin to improve myocardial viability in myocardial preservation followed by reperfusion. Ann Thorac Surg. 52:1991;971-978
12. Gurevitch J., Barak J., Hochhauser E., Paz Y., Yakirevich V. Aprotinin improves myocardial recovery after ischemia and reperfusion. Effects of the drug on isolated rat hearts. J Thorac Cardiovasc Surg. 108:1994;109-118
13. Sunamori M., Innami R., Amano J., Suzuki A., Harrison C.E. Role of protease inhibition in myocardial preservation in prolonged hypothermic cardioplegia followed by reperfusion. Effect of aprotinin in an experimental model. J Thorac Cardiovasc Surg. 96:1988;314-320
14. Khan T.A., Ruel M., Bianchi C., Voisine P., Komjati K., Szabo C., et al. Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass. J Am Coll Surg. 197:2003;270-277
15. Uematsu M., Gaudette G.R., Laurikka J.O., Levitsky S., McCully J.D. Adenosine-enhanced ischemic preconditioning decreases infarct in the regional ischemic sheep heart. Ann Thorac Surg. 66:1998;382-387
16. Bianchi C., Wakiyama H., Faro R., Khan T., McCully J.D., Levitsky S., et al. A novel peroxynitrite decomposer catalyst (FP-15) reduces myocardial infarct size in an in vivo peroxynitrite decomposer and acute ischemia-reperfusion in pigs. Ann Thorac Surg. 74:2002;1201-1207
17. Amsterdam E.A., Stahl G.L., Pan H.L., Rendig S.V., Fletcher M.P., Longhurst J.C. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. Am J Physiol. 268:1995;H448-457
18. Diaz P.E., Fishbein M.C., Davis M.A., Askenazi J., Maroko P.R. Effect of the kallikrein inhibitor aprotinin on myocardial ischemic injury after coronary occlusion in the dog. Am J Cardiol. 40:1977;541-549
19. Bukhari E.A., Krukenkamp I.B., Burns P.G., Gaudette G.R., Schulman J.J., al-Fagih M.R., et al. Does aprotinin increase the myocardial damage in the setting of ischemia and preconditioning? Ann Thorac Surg. 60:1995;307-310
20. Wendel H.P., Heller W., Michel J., Mayer G., Ochsenfahrt C., Graeter U., et al. Lower cardiac troponin T levels in patients undergoing cardiopulmonary bypass and receiving high-dose aprotinin therapy indicate reduction of perioperative myocardial damage. J Thorac Cardiovasc Surg. 109:1995;1164-1172
21. Hendrikx M., Jiang H., Gutermann H., Toelsie J., Renard D., Briers A., et al. Release of cardiac troponin I in antegrade crystalloid versus cold blood cardioplegia. J Thorac Cardiovasc Surg. 118:1999;452-459
22. Asimakopoulos G., Thompson R., Nourshargh S., Lidington E.A., Mason J.C., Ratnatunga C.P., et al. An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation. J Thorac Cardiovasc Surg. 120:2000;361-369
23. Hayashi Y., Sawa Y., Ohtake S., Fukuyama N., Nakazawa H., Matsuda H. Peroxynitrite formation from human myocardium after ischemia-reperfusion during open heart operation. Ann Thorac Surg. 72:2001;571-576
24. Hallett M.B., Shandall A., Young H.L. Mechanism of protection against "reperfusion injury" by aprotinin. Roles of polymorphonuclear leucocytes and oxygen radicals. Biochem Pharmacol. 34:1985;1757-1761
25. Aoki M., Jonas R.A., Nomura F., Stromski M.E., Tsuji M.K., Hickey P.R., et al. Effects of aprotinin on acute recovery of cerebral metabolism in piglets after hypothermic circulatory arrest. Ann Thorac Surg. 58:1994;146-153
26. Kadletz M., Dignan R.J., Loesser K.E., Hess M.L., Wechsler A.S. Ischemia and activated neutrophils alter coronary microvascular but not epicardial coronary artery reactivity. J Thorac Cardiovasc Surg. 108:1994;648-657
27. Vinten-Johansen J., Edgerton T.A., Hansen K.J., Carroll P., Mills S.A., Cordell A.R. Surgical revascularization of acute (1 hour) coronary occlusion blood versus crystalloid cardioplegia. Ann Thorac Surg. 42:1986;247-254
28. Bolling K., Kronon M., Allen B.S., Wang T., Ramon S., Feinberg H. Myocardial protection in normal and hypoxically stressed neonatal hearts the superiority of blood versus crystalloid cardioplegia. J Thorac Cardiovasc Surg. 113:1997;994-1003. discussion 1003-5
29. Ibrahim M.F., Venn G.E., Young C.P., Chambers D.J. A clinical comparative study between crystalloid and blood-based St Thomas' hospital cardioplegic solution. Eur J Cardiothorac Surg. 15:1999;75-83
30. Flack J.E. III, Cook J.R., May S.J., Lemeshow S., Engelman R.M., Rousou J.A., et al. Does cardioplegia type affect outcome and survival in patients with advanced left ventricular dysfunction? Results from the CABG Patch Trial. Circulation. 102:2000;III84-89